User contributions
- 12:46, 19 September 2019 (diff | hist) . . (+1,316) . . N US Food and Drug Administration FDA has issued Boxed Warning due to increased risk of death from gout medicine Uloric febuxostat (Created page with "conduct a large postmarket safety clinical trial. The trial was performed in more than 6,000 patients with gout treated with either Uloric or allopurinol. The main result was...") (current)